JAPAN-SAKE-PR-SECRETARIA
25.7.2022 10:02:04 CEST | Business Wire | Press release
Japan Sake and Shochu Makers Association
(hereafter, “JSS") concluded a partnership agreement with the Association de la Sommellerie Internationale
(hereafter, “ASI”) in May this year.
JSS exchanged greetings at the ASI general assembly held at the “Nagoya Marriott Associa Hotel” in Japan on July 5 and 6, and joined the welcome dinner held the night before. There they had the opportunity to meet and greet representatives of sommelier associations from 22 countries who were visiting Japan. Welcome dinner cuisine was paired with wine and six varieties of Japanese sake.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220719005658/en/
ASI members were invited to a two-day excursion organized by Mie Sake Brewers Association on July 7 and 8. Participants had the valuable opportunity to tour sake breweries in Mie Prefecture, visit the Ise Grand Shrine that is known for its historical links to sake, and explore the rich history and techniques used to make dashi soup stock at katsuobushi (bonito flakes) production plants.
A sake tasting and discussion event with the member breweries of the Mie Sake Brewers Association, followed by the International Sake Conference in Mie
, were held in the evening of July 7 at the “Shima Kanko Hotel,” which attracted worldwide attention in 2016 as the venue for the G7 ISE-SHIMA SUMMIT. A panel discussion led by six panelists including ASI Chairman Wouters covered topics like the potential of Japanese sake as well as international initiatives being planned by JSS.
Representatives from sommelier associations around the world provided a broad range of feedback on how sake could be paired with various styles of cuisines, with many expressing that they would like to try sake with their own country’s culinary specialties.
The reception featured an eight-course meal fusing French cuisine with dashi-inspired flavors and paired with eight local brands of sake, in an ensemble featuring Mie’s three local specialties—ingredients, dashi and sake. This level of hospitality proved to be a source of amazement and inspiration for the leading international sommeliers who had the chance to savor the flavors provided.
The chairs of the Belgian, Serbian, Spanish, and Mexican sommelier associations expressed their desire to work with JSS and schedule sake master classes in the near feature, thus demonstrating the considerable interest that sommeliers have developed for sake.
Looking forward, JSS will coordinate efforts with ASI by providing sake tasting and seminars at events organized by ASI.
Japan Sake and Shochu Makers Association SNS links are as follows.
FB: https://www.facebook.com/japansakeshochu
IG: https://www.instagram.com/japansakeshochu_en/
YouTube: https://www.youtube.com/user/JapanSakeOfficial
Twitter: https://twitter.com/jss_sake_en
View source version on businesswire.com: https://www.businesswire.com/news/home/20220719005658/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release
Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release
A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release
New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release
Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis21.5.2026 13:00:00 CEST | Press release
Randomized controlled trial will evaluate both symptom progression and underlying biology Baszucki Group today announced a £1.17 million grant to support a randomized controlled trial at the University of Oxford assessing the feasibility, safety, and efficacy of a ketogenic diet for patients at clinical high risk of psychosis (CHR-P). Researchers will test this nutritional therapy's ability to improve patients' mental and physical health. This project builds on a growing body of research suggesting the potential of metabolic therapies in treating serious mental illness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521877110/en/ Baszucki Group Funds £1.17 Million for University of Oxford Trial of Ketogenic Therapy for Early Psychosis Psychotic disorders carry a massive personal burden and are associated with a lower life expectancy. Psychosis does not develop immediately, but typically emerges following a period of early
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
